GURU.Markets stock price, segment price, and overall market index valuation
The company's share price ImmuCell Corporation
ImmuCell is a company specializing in dairy cattle health products. Its stock price reflects the state of the dairy industry. Its performance is driven by farmer incomes and demand for products that prevent calf diseases, thereby increasing herd productivity.
Share prices of companies in the market segment - Agricultural resources
ImmuCell Corporation develops and manufactures cattle health products, helping prevent diseases in dairy and beef cows. We've classified it as an "Agro-Resources" company. The chart below shows how investors value companies in the niche veterinary medicine sector.
Broad Market Index - GURU.Markets
ImmuCell Corporation develops and manufactures cattle health products, helping prevent diseases in dairy and beef cows. It is a component of the GURU.Markets index. The chart below represents the market. See how this company's stock compares to the agricultural sector.
Change in the price of a company, segment, and market as a whole per day
ICCC - Daily change in the company's share price ImmuCell Corporation
ImmuCell Corporation's daily price change reflects volatility in the veterinary medicine sector. The indicator demonstrates sensitivity to demand for its cattle health products and regulatory announcements.
Daily change in the price of a set of shares in a market segment - Agricultural resources
ImmuCell Corporation is a company in the veterinary medicine sector. This chart shows average daily volatility. Comparing it to ICCC, which focuses on cattle health, helps understand its unique and non-cyclical nature.
Daily change in the price of a broad market stock, index - GURU.Markets
ImmuCell Corporation develops and markets veterinary products for dairy cattle. It is a niche company in the agricultural sector. Its growth depends on the health of the livestock industry and is part of a larger, more diverse market landscape.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization ImmuCell Corporation
For ImmuCell Corporation, year-over-year performance tells the story of its niche in the cattle health market. Its 12-month market capitalization growth reflects demand for its First Defense product, which prevents diarrhea in newborn calves. The successful approval and launch of a new mastitis drug is key to its future growth.
Annual dynamics of market capitalization of the market segment - Agricultural resources
ImmuCell Corporation specializes in developing cattle health products. Its unique niche in the agricultural sector ensures stable demand. The chart shows how its "protection" business, dependent on the health of the dairy and beef industries, influences its growth.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
ImmuCell, specializing in dairy cattle health, operates in the protective agricultural sector. Demand for its products is driven by farmers' needs, not the state of the economy. The company's stock price reflects this stability, making it less volatile than the overall market and less susceptible to strong economic fluctuations.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization ImmuCell Corporation
ImmuCell produces veterinary medications for dairy cattle. Its business is seasonal, driven by cow calving cycles. Monthly fluctuations in its price reflect demand for its core product, First Defense, and progress in commercializing new products.
Monthly dynamics of market capitalization of the market segment - Agricultural resources
ImmuCell Corporation produces natural products for cattle health, helping to reduce the use of antibiotics in the dairy and meat industries. The graph below shows the overall trend in the agricultural inputs sector, where demand for sustainable solutions is constantly growing.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
ImmuCell Corporation produces veterinary products for dairy cattle. The company's business is dependent on agricultural cycles, particularly milk prices and the health of the dairy industry. Its stock price follows its own agricultural cycle, which rarely aligns with overall stock market trends.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization ImmuCell Corporation
Shares of ImmuCell, a cattle health products company, react weekly to the state of the dairy and meat industries. Milk and beef prices, as well as animal health news, influence farmer demand.
Weekly dynamics of market capitalization of the market segment - Agricultural resources
ImmuCell and the entire animal health sector are responding to the overall state of the agricultural industry. Milk and beef prices, which impact farmers' incomes, are a barometer for the entire industry. This chart will show how the company fares against this backdrop.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
ImmuCell and the entire animal health sector are responding to the overall state of the agricultural industry. Milk and beef prices, which impact farmers' incomes, are a barometer for the entire industry. This chart will show how the company fares against this backdrop.
Market capitalization of the company, segment and market as a whole
ICCC - Market capitalization of the company ImmuCell Corporation
ImmuCell's market capitalization is the financial valuation of a company focused on cattle health. The chart reflects its niche business of producing disease-preventing products for dairy and beef cows. Its stable growth is a story of how solving specific problems in agriculture can create a sustainable business.
ICCC - Share of the company's market capitalization ImmuCell Corporation within the market segment - Agricultural resources
ImmuCell Corporation develops and manufactures cattle health products, helping prevent diseases in newborn calves. Its market share reflects its leadership in this narrow but important veterinary niche. The chart below shows the importance of this "calf protector" in the agribusiness sector.
Market capitalization of the market segment - Agricultural resources
ImmuCell is an agritech company developing cattle health products. The chart below shows the overall market capitalization of the agricultural inputs sector. Its dynamics reflect the importance of animal health to the food industry. ImmuCell occupies a unique and important niche.
Market capitalization of all companies included in a broad market index - GURU.Markets
Animal health, as seen in the chart, is a crucial part of agribusiness. ImmuCell Corporation develops products to prevent diseases in dairy cattle. Its market capitalization is based on its niche products that help improve productivity and reduce antibiotic use on farms.
Book value capitalization of the company, segment and market as a whole
ICCC - Book value capitalization of the company ImmuCell Corporation
The ImmuCell chart represents the material basis for dairy cattle health. Its book value reflects the value of its production facilities, where unique veterinary drugs are created to prevent diseases in newborn calves. These assets support the productivity of the dairy industry.
ICCC - Share of the company's book capitalization ImmuCell Corporation within the market segment - Agricultural resources
ImmuCell Corporation produces veterinary products for dairy cattle. Its stake in the sector is its FDA-approved plant in Maine. This focused and highly specialized physical base is key to its leadership in the animal health niche.
Market segment balance sheet capitalization - Agricultural resources
ImmuCell Corporation produces livestock health products. Its business is moderately capital-intensive, requiring its own USDA-certified production facilities. Compared to the agricultural sector, this demonstrates its commitment to quality control of its niche products.
Book value of all companies included in the broad market index - GURU.Markets
ImmuCell's assets are not human medications, but unique veterinary products that protect newborn calves from disease. The company's balance sheet reflects the value of its niche, yet crucial, dairy industry product. The chart shows the capital invested in the health of the future generation of dairy herds.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - ImmuCell Corporation
ImmuCell Corporation produces veterinary products for dairy cattle. Its value lies in its niche, approved products and its reputation in the industry. Its market capitalization reflects its share of this specific, yet stable, market.
Market to book capitalization ratio in a market segment - Agricultural resources
ImmuCell Corporation produces bovine health products. It's a highly specialized business. This chart shows how the market values its niche products and their share of the veterinary market, making its valuation relatively stable compared to human biotech.
Market to book capitalization ratio for the market as a whole
ImmuCell produces veterinary drugs to prevent diseases in dairy cattle. It is a niche business in the agricultural sector. The chart shows how the market values a company that combines research and development (intangible assets) and production (tangible assets) for a specific but important agricultural market.
Debts of the company, segment and market as a whole
ICCC - Company debts ImmuCell Corporation
ImmuCell Corporation develops and manufactures cattle health products. In agribusiness, borrowed funds can be used to invest in research and development, expand production capacity, and manage seasonal fluctuations in demand from the dairy and meat industries.
Market segment debts - Agricultural resources
ImmuCell Corporation develops and manufactures bovine health products. This is a niche but stable market. This chart illustrates the company's conservative approach to funding, using sales revenue to fund R&D and production, which is typical for established companies in the veterinary sector.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio ImmuCell Corporation
ImmuCell Corporation produces veterinary medications for dairy cattle. This chart shows its debt load. The company operates in a niche market dependent on the health of the agricultural industry. High debt could become a problem if farmers face falling milk prices and begin to cut back on animal health spending.
Market segment debt to market segment book capitalization - Agricultural resources
ImmuCell Corporation develops and manufactures cattle health products, helping fight diseases without the use of antibiotics. This chart compares the company's debt to the total capitalization of the entire agricultural inputs sector. It helps assess how the company finances its important niche in veterinary medicine.
Debt to book value of all companies in the market
ImmuCell Corporation develops and manufactures products for farm animal health. This is a niche but stable market. The chart shows how the company finances its operations and development. Comparing its debt load with the agribusiness and pharmaceutical sectors allows us to assess its financial discipline and growth strategy.
P/E of the company, segment and market as a whole
P/E - ImmuCell Corporation
This chart for ImmuCell, a company that produces veterinary products for dairy cattle, is a barometer of the health of the agricultural sector. Investors' profit estimates depend on the state of the dairy industry and farmers' demand for products to prevent calf diseases. The dynamics reflect these niche, yet stable, factors.
P/E of the market segment - Agricultural resources
This chart shows the average valuation for the animal health sector—the benchmark for ImmuCell. Comparing this niche company's valuation to the broader agricultural sector average helps us understand how investors value its focused business model and stable demand from the dairy industry.
P/E of the market as a whole
ImmuCell develops and markets cattle health products, helping fight diseases without the use of antibiotics. This represents an important niche in modern agriculture. This graph reflects the state of the agricultural sector and helps understand how trends toward sustainable agriculture and the elimination of antibiotics are impacting demand for ImmuCell products.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company ImmuCell Corporation
ImmuCell Corporation produces cattle health products, specifically to prevent diseases in newborn calves. The company's future profits depend on the performance of the dairy and beef industries. This chart shows analysts' assessments of the prospects for these sectors and the demand for products that improve herd productivity.
%20P%2FE%20ImmuCell%20Corporation&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-ImmuCell-Corporation&v=1772643072168 "Chart of the company's future (projected) P/E ImmuCell Corporation")
Future (projected) P/E of the market segment - Agricultural resources
ImmuCell Corporation develops and manufactures bovine health products aimed at preventing and treating diseases in dairy and beef cattle. This chart compares its future profitability expectations with those of the veterinary sector. It helps understand how the market values its niche products and their importance to herd health and productivity.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Agricultural%20resources&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Agricultural-resources&v=1772643072175 "Future (projected) P/E graph of the market segment - Agricultural resources")
Future (projected) P/E of the market as a whole
ImmuCell Corporation produces cattle health products. This chart shows overall sentiment. ICCC's business depends on the state of the dairy and beef industries, milk prices, and herd health. This is the agricultural cycle, which often doesn't correlate with overall stock market sentiment.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772643072178 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit ImmuCell Corporation
ImmuCell Corporation develops and manufactures cattle health products aimed at preventing and treating diseases without the use of antibiotics. This chart shows the company's financial results, which operate in the veterinary sector. Profits are driven by demand from dairy and beef farmers.
Profit of companies in the market segment - Agricultural resources
ImmuCell Corporation develops and manufactures cattle health products that prevent and treat diseases, particularly in newborn calves. This represents a niche segment of the veterinary market. This graph depicts the overall profitability of the agricultural inputs sector, demonstrating the importance of animal health to the efficiency of the dairy and beef industries.
Overall market profit
ImmuCell Corporation develops and markets veterinary products for dairy and beef cattle. Demand for its products depends on the health of the agricultural sector, which has its own cycles linked to milk and beef prices. These cycles may not align with the general industrial cycle shown in this chart.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company ImmuCell Corporation
ImmuCell develops and markets cattle health products that help prevent diseases in newborn calves. This is a niche but important segment of the agribusiness industry. This chart shows analysts' expectations for demand for its products from the dairy and meat industries.
%20profit%20of%20the%20company%20ImmuCell%20Corporation&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-ImmuCell-Corporation&v=1772643072185 "Graph of future (projected) profit of the company ImmuCell Corporation")
Future (predicted) profit of companies in the market segment - Agricultural resources
ImmuCell Corporation develops and manufactures cattle health products aimed at preventing disease without the use of antibiotics. This chart shows forecasts for the veterinary sector. ImmuCell's profitability depends on demand from the dairy and beef industries for effective and natural solutions to maintain herd health.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Agricultural%20resources&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Agricultural-resources&v=1772643072189 "Graph of future (predicted) profits of companies in a market segment - Agricultural resources")
Future (predicted) profit of the market as a whole
ImmuCell Corporation produces veterinary products for dairy cattle, aimed at improving animal health and productivity. Demand for its products depends on the financial health of the dairy industry. This graph, which displays profit forecasts, indirectly indicates future consumer demand for dairy products, which impacts farmers' incomes and investments.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772643072190 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - ImmuCell Corporation
ImmuCell Corporation develops and manufactures bovine health products that prevent diseases in newborn calves. This chart shows how the market values its niche revenue. It reflects the stable demand from the dairy and beef industries for effective veterinary solutions.
P/S market segment - Agricultural resources
ImmuCell Corporation develops and manufactures animal health products aimed at preventing and treating cattle diseases without the use of antibiotics. This represents an important niche in veterinary medicine. This chart reflects the average market value in the agricultural sector, helping to understand how the market values ImmuCell's innovative and in-demand products for the dairy and meat industries.
P/S of the market as a whole
ImmuCell Corporation develops and markets cattle health products that help prevent diseases in newborn calves. This is a niche but important segment of the agribusiness industry. This chart helps assess how the market views the company's revenue, which helps improve the productivity and sustainability of the dairy and beef industries.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company ImmuCell Corporation
ImmuCell Corporation develops and markets cattle health products aimed at preventing diseases without the use of antibiotics. This chart shows how investors estimate the company's future earnings. It reflects the growing trend toward sustainable livestock farming and the demand for natural veterinary products.
%20P%2FS%20ImmuCell%20Corporation&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-ImmuCell-Corporation&v=1772643072215 "The graph of the company's future (projected) P/S ImmuCell Corporation")
Future (projected) P/S of the market segment - Agricultural resources
ImmuCell produces and sells cattle health products. This chart compares the company's estimated future sales with its sector. It reflects the market's appreciation of its niche products, which help dairy and beef farmers fight disease without the use of antibiotics.
%20P%2FS%20market%20segment%20graph%20-%20Agricultural%20resources&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Agricultural-resources&v=1772643072216 "Future (projected) P/S market segment graph - Agricultural resources")
Future (projected) P/S of the market as a whole
ImmuCell Corporation develops and manufactures cattle health products aimed at preventing diseases without the use of antibiotics. This indicator of overall revenue expectations includes the agricultural sector. ImmuCell's growth reflects the trend toward sustainable livestock farming and the reduction of antibiotic use in the food industry.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772643072230 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales ImmuCell Corporation
ImmuCell Corporation develops and markets cattle health products. Its revenue, shown in this chart, is generated primarily from sales of First Defense, a product that prevents diarrhea in newborn calves. The trend reflects demand from the dairy and beef industries.
Sales of companies in the market segment - Agricultural resources
ImmuCell Corporation develops and manufactures animal health products, particularly for dairy cattle, that help fight diseases without the use of antibiotics. This chart illustrates the growth of the veterinary drug market, where demand for natural and effective solutions for livestock production is constantly growing.
Overall market sales
ImmuCell Corporation develops and manufactures cattle health products. Demand for its products depends on the performance of the dairy and beef industries. Growing economic revenues, reflected in this graph, supports consumer demand for dairy products and beef. This allows farmers to invest more in the health of their herds by using ImmuCell products.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company ImmuCell Corporation
ImmuCell Corporation develops and markets cattle health products, specifically for the prevention of diseases in newborn calves. This chart reflects analyst expectations for the dairy and beef industries, the company's primary customers, and demand for its veterinary products.
%20sales%20of%20the%20company%20ImmuCell%20Corporation&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-ImmuCell-Corporation&v=1772643072238 "Schedule of future (projected) sales of the company ImmuCell Corporation")
Future (projected) sales of companies in the market segment - Agricultural resources
ImmuCell Corporation develops and manufactures cattle health products aimed at preventing and treating diseases without the use of antibiotics. This chart shows forecasts for the agricultural inputs sector. It illustrates the growing trend toward sustainable livestock production and the reduction of antibiotic use in the food chain.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Agricultural%20resources&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Agricultural-resources&v=1772643072239 "Schedule of future (projected) sales of companies in the market segment - Agricultural resources")
Future (projected) sales of the market as a whole
ImmuCell, a cattle health specialist, sees this chart as an indicator of the state of the dairy and meat industries. Rising food demand, reflected in overall economic trends, is encouraging farmers to invest in the health and productivity of their herds, creating demand for ImmuCell products.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772643072239 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality ImmuCell Corporation
ImmuCell specializes in the development and production of animal health products, specifically for disease prevention in fresh calves. Profitability in this highly specialized niche depends on the effectiveness of its products and the trust of farmers. This chart shows how successfully the company is monetizing its research and development in the agricultural sector.
Market segment marginality - Agricultural resources
ImmuCell Corporation develops and manufactures cattle health products, specifically to prevent diseases in newborn calves. Profitability in this niche sector depends on the efficiency of biopharmaceutical production and demand from the dairy and meat industries. The chart shows the company's position in the veterinary products sector.
Market marginality as a whole
ImmuCell Corporation develops and markets animal health products aimed at preventing diseases in dairy and beef cattle. This chart shows average profitability, and ImmuCell operates in the veterinary sector. Their profitability depends on farmer demand and the effectiveness of their products in protecting herd health.
Employees in the company, segment and market as a whole
Number of employees in the company ImmuCell Corporation
ImmuCell Corporation develops and manufactures cattle health products. This chart shows its team of scientists, production personnel, and sales specialists. The size of its staff reflects its niche specialization and its efforts to protect the dairy and beef industries from costly diseases.
Share of the company's employees ImmuCell Corporation within the market segment - Agricultural resources
ImmuCell Corporation develops and produces veterinary products to prevent diseases in dairy cattle. This chart shows the share of all specialists in the narrow niche of veterinary biotechnology that ImmuCell attracts. It reflects its focus on animal health and its leadership in creating innovative products for the dairy industry.
Number of employees in the market segment - Agricultural resources
ImmuCell Corporation develops and manufactures bovine health products that prevent diseases in newborn calves. Its staff consists of scientists, production personnel, and sales specialists. This chart shows its operational activities. The team's growth may be due to production expansion and demand from the dairy and meat industries.
Number of employees in the market as a whole
ImmuCell Corporation develops cattle health products. Agriculture operates according to its own cycles, driven by weather, feed, and milk prices. This overall employment schedule may have little correlation with the needs of farmers, who are ImmuCell's primary customers and growth driver.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company ImmuCell Corporation (ICCC)
ImmuCell produces animal health products. This is a niche market that requires scientific development. This indicator reflects the balance between the value of its patents and the efficiency of specialized production aimed at the agricultural sector.
%20of%20the%20company%20ImmuCell%20Corporation%20(ICCC)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-ImmuCell-Corporation-ICCC&v=1772643072289 "Chart of market capitalization per employee (in thousands of dollars) of the company ImmuCell Corporation (ICCC)")
Market capitalization per employee (in thousands of dollars) in the market segment - Agricultural resources
ImmuCell Corporation develops and manufactures cattle health products. In the veterinary and agricultural technology sector, this metric reflects the market share of products and their profitability. The chart helps understand how effectively the company monetizes its research and development work relative to its staff compared to other market players.
%20by%20market%20segment%20-%20Agricultural%20resources&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Agricultural-resources&v=1772643072290 "Market capitalization per employee (in thousands of dollars) by market segment - Agricultural resources")
Market capitalization per employee (in thousands of dollars) for the overall market
ImmuCell Corporation develops and markets cattle health products that prevent diseases in newborn calves. It is a niche veterinary biotech company. This chart shows how the market values the company, whose unique products solve a significant problem in the dairy and meat industries, creating high value per employee.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772643072307 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company ImmuCell Corporation (ICCC)
ImmuCell Corporation develops and manufactures cattle health products (for example, to prevent diarrhea in calves). It is a niche agri-biotech business. This chart shows how efficiently the company produces and sells its specialized veterinary products, generating profit per employee.
%20Chart%20ImmuCell%20Corporation%20(ICCC)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-ImmuCell-Corporation-ICCC&v=1772643072325 "Company Profit Per Employee (in thousands of dollars) Chart ImmuCell Corporation (ICCC)")
Profit per employee (in thousands of dollars) in the market segment - Agricultural resources
ImmuCell (ICCC) specializes in the development and production of cattle health products, specifically for disease prevention in dairy calves. It is a niche agribusiness. This chart shows how efficiently the company produces and sells its specialized veterinary products, generating revenue per employee (scientist, technician, salesperson).
%20in%20the%20market%20segment%20-%20Agricultural%20resources&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Agricultural-resources&v=1772643072362 "Chart of profit per employee (in thousands of dollars) in the market segment - Agricultural resources")
Profit per employee (in thousands of dollars) for the market as a whole
ImmuCell Corporation specializes in cattle health products (veterinary medicine). This is a niche but important sector. This chart shows how successfully the company produces and sells its products. Earnings per employee here depend on the margins of the products (which are often patented) and the effectiveness of the sales team working with farmers.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772643072377 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee ImmuCell Corporation (ICCC)
ImmuCell Corporation develops and manufactures cattle health products. This chart demonstrates the effectiveness of their niche business model. It reflects the revenue generated by a small team from sales of specialized veterinary products, and its growth indicates strong demand from the dairy and meat industries.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-ImmuCell-Corporation-ICCC&v=1772643072443 "Sales chart per company employee ImmuCell Corporation (ICCC)")
Sales per employee in the market segment - Agricultural resources
ImmuCell Corporation specializes in cattle health products, specifically for preventing diseases in newborn calves. It is a niche agri-biotech company. This chart shows the average revenue per employee in the sector. It helps assess how productive ImmuCell is in producing and selling its specialized veterinary products.
Sales per employee for the market as a whole
ImmuCell Corporation (ICCC) specializes in cattle health. Their key product (First Defense) is a supplement that prevents diarrhea in newborn calves. They are a niche agribusiness. This chart shows how successfully their team (R&D, production, and sales) sells this important product to dairy farmers.
Short shares by company, segment and market as a whole
Shares shorted by company ImmuCell Corporation (ICCC)
ImmuCell Corporation produces cattle health products, specifically to prevent diseases in newborn calves. This is a very narrow niche in the agricultural sector. The chart shows the number of investors betting that demand for its core product (First Defense) will stagnate or that the company will be unable to bring new products to market.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-ImmuCell-Corporation-ICCC&v=1772643072562 "Short Shares Chart for the Company ImmuCell Corporation (ICCC)")
Shares shorted by market segment - Agricultural resources
ImmuCell specializes in cattle health products, especially calves (First Defense). Their business is focused on agricultural health. This indicator reflects overall pessimism in the sector. If it's high, investors expect farmers (especially dairy farmers) to face falling prices and cut back on supplements, which will hurt everyone.
Shares shorted by the overall market
ImmuCell specializes in cattle health products, preventing diseases in calves. It's a niche agricultural biotech company. This chart illustrates the overall market pessimism. While food is always needed, during downturns, farmers may skimp on preventative medications. Investors also avoid illiquid stocks of small companies, like ICCC, in times of fear.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator ImmuCell Corporation (ICCC)
ImmuCell Corporation specializes in cattle health products, helping dairy and beef farmers. Their business is dependent on agricultural cycles. This chart shows how investors react to milk prices or beef demand, reflecting "overbought" (above 70) at the peak of the cycle or "oversold" (below 30) at the decline.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-ImmuCell-Corporation-ICCC&v=1772643072646 "RSI 14 indicator chart for the company's stock ImmuCell Corporation (ICCC)")
RSI 14 Market Segment - Agricultural resources
ImmuCell (ICCC) is "immunity" for *cows*. They're *not* Zoetis, but a *niche* player: they make *antibodies* (First Defense) to *protect newborn calves* from *diarrhea*. The "Agricultural Resources" (agritech) sector thrives on hype. RSI\_14\_Seg shows the "temperature" of the *entire* industry. It helps us understand: is ICCC's growth a niche product or a result of the *general* hype?
RSI 14 for the overall market
ImmuCell (ICCC) produces livestock health products. This chart shows that its business is "defensive." Demand for cow health (the backbone of the dairy industry) is unaffected by euphoria or panic. During periods of market panic, investors seek safe havens in stable, non-cyclical sectors.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast ICCC (ImmuCell Corporation)
ImmuCell is a company focused on animal health, particularly for cattle. Their key product (First Defense) protects newborn calves from disease. This chart shows the analysts' average 12-month forecast. It reflects their view on the state of the dairy and meat industries and demand for their niche products.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-ICCC-ImmuCell-Corporation&v=1772643072889 "A chart showing analyst consensus forecasts for the expected stock price. ICCC (ImmuCell Corporation)")
The difference between the consensus estimate and the actual stock price ICCC (ImmuCell Corporation)
ImmuCell is a unique agri-biotech company. It produces natural products (First Defense) to protect newborn calves from diseases. This chart measures the gap between the current price and the consensus target price. It shows whether experts believe in their ability to scale up production and demand from the dairy and meat industries.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-ICCC-ImmuCell-Corporation&v=1772643072915 "A chart showing the difference between the consensus forecast and the actual stock price. ICCC (ImmuCell Corporation)")
Analyst consensus forecast for stock prices by market segment - Agricultural resources
ImmuCell is a niche company in animal health. Its flagship product, "First Defense," protects newborn calves from diarrhea. Its business is directly dependent on the health of the dairy and beef industries. This chart shows analysts' overall expectations for the entire agricultural sector. It reflects whether experts believe in the growth and profitability of livestock farming.
Analysts' consensus forecast for the overall market share price
ImmuCell Corporation is a company specializing in animal health. Their key product (First Defense) is a treatment for newborn calves that protects them from intestinal infections. This chart shows the overall market sentiment. For ImmuCell, which operates in the protective agricultural sector (livestock health is essential), overall optimism is important, but their business is less dependent on economic cycles than other sectors.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index ImmuCell Corporation
ImmuCell is a niche but critical player in the agricultural economy. They specialize in animal health, producing products that prevent scours in newborn calves. Their business is a direct proxy for the health of the dairy and meat industries. This chart is an integral indicator of this niche. It reflects their sales, their R&D pipeline for new animal treatments, and seasonal cycles.
AKIMA Market Segment Index - Agricultural resources
ImmuCell Corporation (ICCC) is a biotechnology company in the agricultural sector. It develops and markets products (such as First Defense) to prevent and treat diseases in cattle. The chart shows the average index for the segment, allowing investors to assess how well ImmuCell performs in its animal health niche compared to the average in the agricultural sector.
The AKIM Index for the overall market
ImmuCell is a biotech company specializing in animal health (dairy and beef cattle). It produces immune-boosting products. This chart, which reflects the market average, is a backdrop. It helps assess how ICCC, a niche player in agribusiness, compares to general macroeconomic fluctuations and milk/meat prices.
